Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.

Authors:
Sørensen CA; Jeffery L; Falhof J; Harbig P; Roelsgaard K and 2 more

Journal:
Ther Adv Drug Saf

Publication Year: 2023

DOI:
10.1177/20420986231159221

PMCID:
PMC10026123

PMID:
36949765

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Ther Adv Drug Saf

Abbreviation: Ther Adv Drug Saf

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass in…
Shaikh F; Wynne R; L Castelino R and 3 more (2024) - Transparency Score: 3/6
Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Eve…
Jiang T; Su H; Xu J and 9 more (2024) - Transparency Score: 3/6
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition betwe…
Sørensen CA; Jeffery L; Roelsgaard K and 4 more (2023) - Transparency Score: 3/6
Analysis of the nature and contributory factors of medication safety incidents following hospital d…
Alqenae FA; Steinke D; Carson-Stevens A and 1 more (2023) - Transparency Score: 3/6
Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance u…
Altebainawi AF; Alfaraj LA; Alharbi AA and 2 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article."

Evidence found in paper:

"Funding: The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The study was funded by the Central Denmark Region Health Science Research Foundation, the Central Denmark Region Health Innovation Foundation, the Hospital Pharmacies and Amgros’ Research and Development Foundation and the Hospital Pharmacy Central Denmark Region."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025